Browsing: Longevity

Long-term data suggest newly approved therapy can change trajectory of a rare inherited form of ALS, with sustained gains in…

Study links statin use to slower cognitive decline in Alzheimer’s patients, prompting renewed interest in repurposing common heart drugs. Long…

Longevity-linked enzyme shown to regulate brain metabolism, opening drug and biomarker opportunities for aging-related neurological disease. A newly identified role…

CPN expands beauty and wellness push, partnering with 690 brands to tap Thailand’s fast-growing longevity-driven market. Thailand’s largest commercial property…

By targeting a hidden toxic protein, an experimental drug could change how Alzheimer’s is prevented and treated. For decades, Alzheimer’s…

Partnership targets cold-chain bottlenecks by combining hydrogel preservation with human-relevant organoid platforms. Atelerix, a UK-based biotech focused on non-cryogenic cell…

From models and measurement to clinics and competition, 2025 marked the moment longevity began behaving like a field with consequences.…

Anavex is pushing for a second look at a potential early Alzheimer’s treatment in a move that could reshape the…

Liom boasts miniaturization breakthrough in spectroscopy-powered continuous glucose monitoring technology.   Swiss healthtech startup Liom has secured a $16.5 million…

US President says agreements with more drugmakers will lower costs for patients; critics question what savings consumers will actually see.…